Indications and adverse events of teriparatide: based on fda adverse event reporting system (faers)

HIGHLIGHTS

• What: The primary systematically applying these algorithms to mine the FAERS data, this study aimed to identify safety signals for teriparatide comprehensively and reliably. At the preferred term (PT) level, the study utilized four algorithms to analyze AERs and evaluate their adherence to various screening criteria, resulting in 318 PTs, as shown in Supplementary Table S1, and the waterfall plot of all AEs signal intensities of PT level is shown in Figure 3. The study has unearthed numerous postmarketing safety signals congruent with clinical trials, alongside reports necessitating further regulatory scrutiny to ascertain their significance.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.